+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Glucose Monitoring Devices Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895086
The global glucose monitoring devices market was valued at USD 17.5 billion in 2023, driven by the increasing prevalence of diabetes across the globe. The market size is anticipated to grow at a CAGR of 11.3% during the forecast period of 2024-2032 to achieve a value of USD 46 billion by 2032.

Glucose Monitoring Devices: Introduction

Glucose monitoring devices are medical tools designed to measure and monitor the levels of glucose, or sugar, in a person's blood. These devices play a critical role in managing diabetes, a chronic condition characterized by the body's inability to regulate blood sugar levels effectively. Traditionally, individuals with diabetes relied on manual methods such as urine testing or fingerstick blood tests to monitor their glucose levels. However, technological advancements have led to the development of more convenient and accurate glucose monitoring devices.

Advancements in glucose monitoring technology have also led to the integration of insulin pumps with CGM systems. These devices known as hybrid, closed-loop systems or artificial pancreas systems, can automatically adjust insulin delivery based on real-time CGM data, further improving diabetes management.

Key Trends in the Global Glucose Monitoring Devices Market

The glucose monitoring devices market has been witnessing several key trends driven by technological advancements, changing demographics, and increasing awareness about diabetes management. Some of the prominent trends in the market include:

  • Continuous Glucose Monitoring (CGM) Dominance: CGM devices have gained significant popularity and are expected to continue dominating the market. These devices provide real-time glucose readings, trend analysis, and alerts, enabling better diabetes management and reducing the need for frequent fingerstick tests.
  • Integration of Insulin Delivery Systems: The integration of insulin pumps with CGM devices, known as hybrid, closed-loop systems or artificial pancreas systems, is a growing trend. These systems can automatically adjust insulin delivery based on real-time glucose data, providing a more seamless and automated approach to diabetes management.
  • Miniaturization and Wearable Devices: Glucose monitoring devices are becoming smaller, more discreet, and wearable. Manufacturers are focusing on developing compact and comfortable devices that can be worn on the body, such as on the arm or abdomen.
  • Connectivity and Digital Health: The integration of glucose monitoring devices with digital health platforms and smartphone applications is gaining momentum. This connectivity enables users to track and analyse their glucose data, set reminders, receive alerts, and share information with healthcare professionals remotely.
  • Artificial Intelligence and Data Analytics: The use of artificial intelligence (AI) and data analytics in glucose monitoring is on the rise. AI algorithms can analyse large volumes of glucose data, identify patterns, and provide personalized insights and recommendations for diabetes management.

Global Glucose Monitoring Devices Market Segmentations

The market can be categorized into product type, applications, distribution channel, end user, and region.

Market Breakup by Product Type

Self-Monitoring Blood Glucose Devices

  • Glucose Strips
  • Blood Glucose Metre
  • Lancets

Continuous Glucose Monitoring Devices

  • Sensors
  • Transmitters and Receiver
  • Insulin Pumps
  • Others

Market Breakup by Applications

  • Type-1 Diabetes
  • Type-2 Diabetes

Market Breakup by Distribution Channel

  • Retail
  • Specialty Stores
  • Drug Stores/Pharmacies
  • Online
  • Others

Market Breakup by End user

  • Hospitals
  • Clinics
  • Diagnostic Centres
  • Home Healthcare
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Glucose Monitoring Devices Market Overview

The glucose monitoring devices market is a rapidly growing sector within the global healthcare industry. It encompasses a wide range of devices and technologies used for measuring and monitoring glucose levels in individuals with diabetes. The market is driven by factors such as the increasing prevalence of diabetes, technological advancements, and the growing focus on proactive diabetes management.

The market size of glucose monitoring devices has been expanding significantly in recent years. The glucose monitoring devices market is geographically diverse, with significant growth potential in various regions. North America has traditionally been the largest market due to the high prevalence of diabetes and advanced healthcare infrastructure. Europe is also a prominent market, driven by increasing awareness and government initiatives for diabetes management. The Asia-Pacific region, including countries like China and India, is witnessing rapid growth due to the rising prevalence of diabetes, improving healthcare infrastructure, and increasing disposable incomes.

Key Players in the Global Glucose Monitoring Devices Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in glucose monitoring devices market are as follows:

  • Abbott Laboratories
  • Medtronic plc.
  • F. Hoffmann-La Roche Ltd.
  • Ascensia Diabetes Care
  • Dexcom, Inc.
  • Sanofi
  • Novo Nordisk
  • Insulet Corporation
  • Ypsomed Holdings
  • Glysens Incorporated
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Glucose Monitoring Devices Market Overview
3.1 Global Glucose Monitoring Devices Market Historical Value (2017-2023)
3.2 Global Glucose Monitoring Devices Market Forecast Value (2024-2032)
4 Global Glucose Monitoring Devices Market Landscape
4.1 Global Glucose Monitoring Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Glucose Monitoring Devices Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Glucose Monitoring Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Glucose Monitoring Devices Market Segmentation
6.1 Global Glucose Monitoring Devices Market by Product Type
6.1.1 Self-Monitoring Blood Glucose Devices
6.1.1.1 Glucose Strips
6.1.1.2 Blood Glucose Metre
6.1.1.3 Lancets
6.1.2 Continuous Glucose Monitoring Devices
6.1.2.1 Sensors
6.1.2.2 Transmitters and Receiver
6.1.2.3 Insulin Pumps
6.1.2.4 Others
6.2 Global Glucose Monitoring Devices Market by Applications
6.2.1 Market Overview
6.2.2 Type-1 Diabetes
6.2.3 Type-2 Diabetes
6.3 Global Glucose Monitoring Devices Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Retail
6.3.3 Speciality Stores
6.3.4 Drug Stores/Pharmacies
6.3.5 Online
6.3.6 Others
6.4 Global Glucose Monitoring Devices Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Clinics
6.4.4 Diagnostic Centres
6.4.5 Home Healthcare
6.4.6 Others
6.5 Global Glucose Monitoring Devices Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Glucose Monitoring Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Glucose Monitoring Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Glucose Monitoring Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Glucose Monitoring Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Glucose Monitoring Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Abbott Laboratories
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Medtronic plc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 F. Hoffmann-La Roche Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Ascensia Diabetes Care
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Dexcom, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Sanofi
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Novo Nordisk
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Insulet Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Ypsomed Holdings
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Glysens Incorporated
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
18 Global Glucose Monitoring Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Abbott Laboratories
  • Medtronic plc.
  • F. Hoffmann-La Roche Ltd.
  • Ascensia Diabetes Care
  • Dexcom Inc.
  • Sanofi
  • Novo Nordisk
  • Insulet Corporation
  • Ypsomed Holdings
  • Glysens Incorporated

Methodology

Loading
LOADING...